BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 8805759)

  • 1. Statistical significance of combinatorial regulations.
    Terada A; Okada-Hatakeyama M; Tsuda K; Sese J
    Proc Natl Acad Sci U S A; 2013 Aug; 110(32):12996-3001. PubMed ID: 23882073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Permutational Multiple Testing Adjustments With Multivariate Multiple Group Data.
    Troendle JF; Westfall PH
    J Stat Plan Inference; 2011 Jun; 141(6):2021-2029. PubMed ID: 21516184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple comparisons between two groups on multiple Bernoulli outcomes while accounting for covariates.
    Troendle JF
    Stat Med; 2005 Dec; 24(23):3581-91. PubMed ID: 15977268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantile-function based null distribution in resampling based multiple testing.
    van der Laan MJ; Hubbard AE
    Stat Appl Genet Mol Biol; 2006; 5():Article14. PubMed ID: 17049025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Step-up multiple testing of parameters with unequally correlated estimates.
    Dunnett CW; Tamhane AC
    Biometrics; 1995 Mar; 51(1):217-27. PubMed ID: 7766777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple testing to establish superiority/equivalence of a new treatment compared with k standard treatments for unbalanced designs.
    Kwong KS; Cheung SH; Chan WS
    Biometrics; 2004 Jun; 60(2):491-8. PubMed ID: 15180675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Dunnett-Bonferroni-based parallel gatekeeping procedure for dose-response clinical trials with multiple endpoints.
    Xu H; Nuamah I; Liu J; Lim P; Sampson A
    Pharm Stat; 2009; 8(4):301-16. PubMed ID: 19065544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A permutational step-up method of testing multiple outcomes.
    Troendle JF
    Biometrics; 1996 Sep; 52(3):846-59. PubMed ID: 8805759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to deal with multiple treatment or dose groups in randomized clinical trials?
    Hothorn LA
    Fundam Clin Pharmacol; 2007 Apr; 21(2):137-54. PubMed ID: 17391286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The problem of multiple testing and solutions for genome-wide studies].
    Gyorffy B; Gyorffy A; Tulassay Z
    Orv Hetil; 2005 Mar; 146(12):559-63. PubMed ID: 15853065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imputation strategies for missing continuous outcomes in cluster randomized trials.
    Taljaard M; Donner A; Klar N
    Biom J; 2008 Jun; 50(3):329-45. PubMed ID: 18537126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of methods for futility stopping based on conditional power.
    Lachin JM
    Stat Med; 2005 Sep; 24(18):2747-64. PubMed ID: 16134130
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.